"MetaVia OXM analogue agonist meets endpoints in Phase Ib weight loss trial" was originally created and published by Clinical ...

Many people who stop using weight loss drugs will return to their previous weight within two years, a new review of existing ...

Running fights junk food’s mental toll—healing the gut, balancing hormones, and protecting the brain.

Biomed Industries to Advance NA-931 Into Two Global Phase 3 Trials as Monotherapy and in Combination With Semaglutide and Tirzepatide for Obesity Advancing NA-931 into two Phase 3 programs as ...

Peptides have emerged as critical tools in the investigation of physiological homeostasis, specifically in how biological systems manage energy substrates and recover from physical trauma. By ...

MetaVia Inc. (Nasdaq: MTVA), a clinical-stage biotechnology company focused on transforming cardiometabolic diseases, today announced positive statistically significant results from the 8-week ...

Though it has long been recognized that the liver exhibits remarkable immune tolerance, the underlying mechanisms driving ...

Registered dietitians share the best protein choices to support muscle, energy and sustainable weight loss while taking a GLP ...

Study is Evaluating Monthly Subcutaneous, Weekly Oral, and Daily Oral Regimens Designed to Explore Maintenance Dosing Regimens Following Initial Weight Loss with VK2735 ...

“Orforglipron and retatrutide from Eli Lilly exemplify the next generation of metabolic therapies: oral formulations that promise improved adherence, triple-hormone mechanisms that deliver superior ...

Some dietary supplements may help naturally boost GLP-1, but more research is needed to better understand their potential ...

January 8, 2026 - By Amy Anderson - Adults aged 65 and older's desire to lose weight is frequently centered around improving functional ability and health outcomes, which may differ from those of ...